SeekingAlpha · Apr 8, 2026
CURE: Pullback In Healthcare Stocks Presents A Buying Opportunity
CURE ETF slid in early 2026 as investors take profits.
CU
AMEX · CURE
Direxion Daily Healthcare Bull 3X Shares
Financial Services · Asset Management
$129.32
Up+$2.27 (+1.79%)
Updated Sep 18, 2026, 6:44 AM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 214.87M
- P/E ratio
- —
- Dividend yield
- 0.83%
- 52-week range
- $82.41 – $150.00
- Volume
- 25.12K
- Avg. volume
- 133.66K
Price performance
CURE price history
1M range · 20 trading sessions · Daily adjusted prices
CURE closed at $129.32 after 20 trading sessions, down 7.63% for the selected period.
- Last close
- $129.32
- Period change
- -7.63%
- Period low
- $121.88
- Period high
- $146.59
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $128.74 | $130.00 | $127.25 | $129.32 | 25.12K |
| Sep 16, 2026 | $127.20 | $129.165 | $126.30 | $127.05 | 21.45K |
| Sep 15, 2026 | $127.07 | $127.43 | $123.66 | $126.86 | 40.5K |
| Sep 14, 2026 | $127.30 | $129.00 | $125.77 | $127.00 | 75.77K |
| Sep 11, 2026 | $125.15 | $125.60 | $121.56 | $121.88 | 38.84K |
| Sep 10, 2026 | $124.76 | $125.53 | $122.53 | $122.84 | 30.09K |
| Sep 9, 2026 | $126.58 | $126.58 | $124.24 | $124.80 | 45.25K |
| Sep 8, 2026 | $129.05 | $129.77 | $125.7503 | $126.16 | 71.48K |
| Sep 4, 2026 | $136.465 | $138.775 | $135.85 | $136.48 | 70.35K |
| Sep 3, 2026 | $142.68 | $143.2905 | $136.47 | $141.15 | 74.6K |
| Sep 2, 2026 | $138.86 | $143.555 | $138.86 | $140.34 | 47.43K |
| Sep 1, 2026 | $139.31 | $141.50 | $135.9599 | $137.05 | 67.35K |
| Aug 31, 2026 | $134.16 | $135.60 | $131.5773 | $134.62 | 65.17K |
| Aug 28, 2026 | $136.46 | $136.93 | $134.96 | $136.19 | 47.77K |
| Aug 27, 2026 | $138.78 | $141.00 | $136.76 | $137.23 | 72.21K |
| Aug 26, 2026 | $144.72 | $145.25 | $141.79 | $142.35 | 41.07K |
| Aug 25, 2026 | $144.28 | $147.75 | $143.995 | $146.59 | 38.22K |
| Aug 24, 2026 | $144.71 | $145.61 | $142.14 | $144.96 | 114.96K |
| Aug 21, 2026 | $138.48 | $147.00 | $138.48 | $144.69 | 67.72K |
| Aug 20, 2026 | $144.00 | $146.53 | $139.45 | $140.00 | 74.23K |
Latest CURE news
The latest Smart Investors Daily articles mentioning CURE.
Stock researchCompany · Overview
CURE research
Overview
Company profile and research snapshot.
Company profile
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
seekingalpha.com · Nov 26, 2025
CURE: Analysts Strike A Cautious Tone Heading Into 2026
The Direxion Daily Healthcare Bull 3X Shares ETF has meaningfully outperformed the S&P 500 so far in 2025, benefiting from a recent shift in sentiment toward health care stocks. While CURE's underlying index is not as cheap as it was a few months ago, it still offers a roughly 19% forward P/E discount relative to the S&P 500. After strong recent returns, analysts project modest single-digit gains over the next 12 months for CURE's largest holdings.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
